Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Telesis Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Telesis Bio, Inc. Earnings Date And Information
Telesis Bio, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-3.83 earnings per share for the quarter, topping analysts' consensus estimates of $-5.3 by $1.47. The company had revenue of 1.57 M for the quarter and had revenue of 27.51 M for the year. Telesis Bio, Inc. has generated $-2 earnings per share over the last year ($-29.56 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. Telesis Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Telesis Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | -$3.92 | N/A | $2.00 M | $1.57 M |
| 06/29/2024 | Q2 2024 | N/A | -$7.62 | N/A | $6.50 M | $1.55 M |
| 03/29/2024 | Q1 2024 | N/A | -$0.29 | N/A | N/A | $3.44 M |
| 12/29/2023 | Q4 2023 | N/A | -$0.59 | N/A | N/A | $6.98 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.35 | N/A | $7.40 M | $5.56 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.28 | N/A | $8.60 M | $8.65 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.37 | N/A | N/A | $6.32 M |
| 12/31/2022 | Q4 2022 | N/A | -$0.28 | N/A | N/A | $9.47 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.42 | N/A | $5.30 M | $6.68 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.50 | N/A | $4.60 M | $5.66 M |
| 03/31/2022 | Q1 2022 | N/A | -$0.45 | N/A | N/A | $5.64 M |
| 12/31/2021 | Q4 2021 | N/A | -$0.43 | N/A | N/A | $3.08 M |
| 09/30/2021 | Q3 2021 | N/A | -$0.34 | N/A | $2.93 M | $2.79 M |
| 08/05/2021 | Q2 2021 | N/A | -$0.32 | N/A | $2.53 M | $2.85 M |
| 05/06/2021 | Q1 2021 | N/A | -$0.26 | N/A | N/A | $2.33 M |
| 03/01/2021 | Q4 2020 | N/A | -$0.22 | N/A | N/A | $1.94 M |
| 11/05/2020 | Q3 2020 | $0.20 | -$0.21 | -0.41 | N/A | $1.64 M |
| 08/06/2020 | Q2 2020 | -$0.43 | -$0.19 | 0.24 | N/A | $1.62 M |
| 05/07/2020 | Q1 2020 | -$0.46 | -$0.18 | 0.28 | N/A | $1.39 M |
| 03/12/2020 | Q4 2019 | -$0.42 | -$0.52 | -0.1 | N/A | $3.89 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Telesis Bio, Inc. Earnings: FAQ's
Telesis Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based offlast year's report dates.
In the previous quarter, Telesis Bio, Inc. (:TBIO) reported $-3.83 earnings per share (EPS) to beat the analysts' consensus estimate of $-5.3 by $1.47.
The conference call for Telesis Bio, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Telesis Bio, Inc.'s latest earnings report can be read online.
Telesis Bio, Inc. (:TBIO) has a recorded annual revenue of $27.51 M.
Telesis Bio, Inc. (:TBIO) has a recorded net income of $-47,724,000.Telesis Bio, Inc. has generated $-1.64 earnings per share over the last four quarters.
Telesis Bio, Inc. (:TBIO) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is 0.